bf/NASDAQ:FENC_icon.jpeg

NASDAQ:FENC

Fennec Pharmaceuticals Inc.

  • Stock

USD

Last Close

8.00

06/11 21:00

Market Cap

163.93M

Beta: 0.16

Volume Today

65.31K

Avg: 80.91K

PE Ratio

−11.72

PFCF: −16.43

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-2.18M
-
-659K
69.72%
-2.79M
323.22%
-7.05M
152.64%
-9.89M
40.33%
-12.78M
29.20%
-18.11M
41.75%
-17.35M
4.21%
-23.71M
36.71%
-16.34M
31.10%
depreciation and amortization
64K
-
402K
528.13%
14K
96.52%
132K
842.86%
221K
67.42%
deferred income tax
-64K
-
-402K
528.13%
-14K
96.52%
7.46M
-
stock based compensation
627K
-
97K
84.53%
615K
534.02%
1.52M
146.67%
1.82M
20.30%
2.67M
46.03%
2.79M
4.73%
3.75M
34.32%
4.09M
9.02%
5.35M
31.00%
change in working capital
120K
-
-63K
152.50%
10K
115.87%
1.01M
10,030%
132K
86.97%
569K
331.06%
-763K
234.09%
-932K
22.15%
1.10M
218.35%
-6.90M
725.78%
accounts receivables
-1.54M
-
-7.40M
379.11%
inventory
-576K
-
-1.61M
179.34%
accounts payables
-11K
-
-54K
390.91%
611K
1,231.48%
177K
71.03%
580K
227.68%
-41K
107.07%
-794K
1,836.59%
1.61M
303.02%
1.41M
12.32%
other working capital
-52K
-
64K
223.08%
402K
528.13%
-45K
111.19%
-11K
75.56%
-722K
6,463.64%
-138K
80.89%
1.61M
1,268.12%
695.52K
56.85%
other non cash items
-270K
-
-1.24M
358.15%
40K
103.23%
875K
2,087.50%
105K
88%
481K
358.10%
486K
1.04%
307K
36.83%
334K
8.79%
-7.25M
2,271.21%
net cash provided by operating activities
-1.70M
-
-1.86M
9.59%
-2.12M
14.07%
-3.64M
71.42%
-7.83M
114.94%
-9.06M
15.77%
-15.60M
72.13%
-14.22M
8.80%
-18.06M
26.97%
-17.46M
3.33%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
debt repayment
-4.94M
-
-5M
1.17%
-5.09M
1.83%
common stock issued
2.18M
-
5M
-
27.38M
447.62%
31.97M
-
-7.93K
100.02%
723.16K
9,219.79%
1.75M
141.64%
common stock repurchased
-194K
-
dividends paid
-529.16K
-
other financing activites
161K
-
497K
208.70%
108K
78.27%
594K
450%
2.35M
295.12%
-71K
103.03%
322K
553.52%
9.93M
2,983.25%
25.73M
159.18%
-79.43K
100.31%
net cash used provided by financing activities
2.34M
-
497K
78.79%
5.11M
927.77%
27.98M
447.67%
2.35M
91.61%
-71K
103.03%
32.29M
45,577.46%
4.98M
84.58%
20.73M
316.47%
6.76M
67.39%
effect of forex changes on cash
net change in cash
644K
-
-1.36M
311.96%
2.98M
318.61%
24.33M
715.48%
-5.48M
122.52%
-9.13M
66.65%
16.69M
282.83%
-9.24M
155.37%
2.67M
128.93%
-10.56M
494.99%
cash at beginning of period
1.66M
-
2.31M
38.73%
942K
59.17%
3.93M
316.77%
28.26M
619.82%
22.78M
19.39%
13.65M
40.08%
30.34M
122.30%
21.10M
30.46%
23.76M
12.62%
cash at end of period
2.31M
-
942K
59.17%
3.93M
316.77%
28.26M
619.82%
22.78M
19.39%
13.65M
40.08%
30.34M
122.30%
21.10M
30.46%
23.77M
12.67%
13.20M
44.47%
operating cash flow
-1.70M
-
-1.86M
9.59%
-2.12M
14.07%
-3.64M
71.42%
-7.83M
114.94%
-9.06M
15.77%
-15.60M
72.13%
-14.22M
8.80%
-18.06M
26.97%
-17.46M
3.33%
capital expenditure
free cash flow
-1.70M
-
-1.86M
9.59%
-2.12M
14.07%
-3.64M
71.42%
-7.83M
114.94%
-9.06M
15.77%
-15.60M
72.13%
-14.22M
8.80%
-18.06M
26.97%
-17.46M
3.33%

All numbers in USD (except ratios and percentages)